Publications
Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.
PUBLICATION
Regional Vulnerability in Huntington’s disease: fMRI-guided Molecular Analysis in Patients and a Mouse Model of disease
PUBLICATION
Comprehensive Behavioral and Molecular characterization of a new knock-in Mouse Model of Huntington’s disease: zQ175
PUBLICATION
Insights into the Structural Determinants Required for High Affinity Binding of Chiral Cyclopropane-Containing Ligands to α4β2-Nicotinic Acetylcholine Receptors; An Integrated Approach to Behaviorally Active Nicotinic Ligands.
PUBLICATION
Functional Improvement in Mouse Models of Familial Amyotrophic Lateral Sclerosis by PEGylated insulin-like Growth Factor I Treatment Depends on Disease Severity .
PUBLICATION
Prediction of Death in the SMNΔ Mouse Model of Spinal Muscular Atrophy: Insight into Disease Stage and Progression. Journal of Neuroscience Methods.
PUBLICATION
Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, that Prolongs the Median Survival Time of Ä7 SMA KO Mouse Model of Spinal Muscular Atrophy.
PUBLICATION
Effect of the Rd1 Mutation on Motor Performance in R6/2 and Wild Type Mice. PLoS Currents Huntington Disease.
PUBLICATION
Identification of Novel alpha4 beta2-Nicotinic Acetylcholine Receptor (nAChR) Agonists Based on an Isoxazole Ether Scaffold that Demonstrate Antidepressant-like Activity. Journal of medicinal chemistry.
PUBLICATION
